https://www.europeanpharmaceuticalreview.com/news/merck-to-divest-cdmo-business-across-five-us-sites-to-lonza/2136921.article European Pharmaceutical Review en 2026-11-04T11:28:00+00:00 Merck to divest CDMO business across five US sites to Lonza CDMO/CMO operations,Regulation and compliance https://www.europeanpharmaceuticalreview.com/news/fda-finalises-cell-and-gene-therapy-potency-guidance/2136916.article European Pharmaceutical Review en 2026-11-03T12:17:00+00:00 ​FDA finalises cell and gene therapy potency guidance Analytical and bioanalysis,Bioprocessing and biomanufacturing,Regulation and compliance